RNU4ATAC8P

Across TCGA pan-cancer cohorts, RNU4ATAC8P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU4ATAC8P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU4ATAC8P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU4ATAC8P expression acts as an unfavorable survival marker.

SKCM, KIRC, and SARC are the cancer types where RNU4ATAC8P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.111	0.877	<.001	108	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	36	view →
STAD	DFS	Tertile	All	0.190	0.546	.004	27	view →
GBM	DFS	Tertile	All	0.064	0.257	.014	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU4ATAC8P–SKCM (OS)

Open the SKCM breakdown →